Monday, June 15, 2026

“USA May Have No Possibility of Execution of ‘Leadership Elimination Operation’ Against North Korea like Against Venezuela

Experts believe Trump won't target North Korea's leadership like Maduro, but pressure tactics may increase nuclear tensions.

Yoon’s Approval Ratings Plummet: Is the President Hiding from Scandal?

The Democratic Party of Korea criticized President Yoon over an audio file suggesting his involvement in candidate nominations.

Despite Tariff Relief, U.S. Inflation Fears Hit 44-Year High

Despite a 90-day tariff suspension, inflation fears rise, with consumer sentiment at its lowest since 1978, impacting economic growth.

Tag: agreement

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Texas Dolce Project Marks New Step in Korea Southern Power’s North American Energy Storage Strategy

Korea Southern Power signed a joint development agreement for the Dolce BESS project in Texas with HD Hyundai Electric and others.

Curiosis Expands Revvity Partnership With 110 Billion KRW Supply Deal for Live-Cell Imaging Systems

Curiosis expands its partnership with Revvity, boosting a supply contract for live cell imaging systems to 110 billion KRW, enhancing market reach.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

How Celltrion is Tackling U.S. Tariff Risks with New Production Facility in 2026

Celltrion addresses tariff risks by acquiring a U.S. facility, ensuring product supply and implementing strategies to mitigate uncertainties.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.